Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Ann Surg Oncol. 2021 Feb 22;28(9):5121–5131. doi: 10.1245/s10434-021-09710-8

Table IV.

Estimated Risk for a Complication in Two Hypothetical Patients

Patient 1: 46 y/o white female with PMH of HTN, normal BMI, presenting with DCIS Complication Composite
Infectious Hematologic Internal Organ Overall
Partial Mastectomy 1.2 % 0.1 % 0.1 % 1.5 %
Oncoplastic Surgery* 3.5 % 2.0 % 0.4 % 6.0 %
Mastectomy Alone 3.1 % 0.6 % 0.2 % 3.9 %
Mastectomy Implant Reconstruction* 4.7 % 1.6 % 0.4 % 6.6 %
Mastectomy with Muscular Flap Reconstruction* 7.0 % 9.6 % 0.8 % 15.9 %

Patient 2: 66 y/o white female with PMH of obesity, COPD, smoking, presenting with IvBC Complication Composite
Infectious Hematologic Internal Organ Overall
Partial Mastectomy 2.7 % 0.2 % 0.4 % 3.3 %
Oncoplastic Surgery* 6.3 % 1.9 % 1.1 % 9.4 %
Mastectomy Alone 5.3 % 0.5 % 0.5 % 6.3 %
Mastectomy Implant Reconstruction* 8.2 % 1.6 % 1.1 % 10.9 %
Mastectomy with Muscular Flap Reconstruction* 13.6 % 6.0 % 2.2 % 21.8 %
*

Reconstructive procedures are treated as inpatient; PMH, past medical history; HTN, hypertension; BMI, body mass index; DCIS, ductal carcinoma in situ; IvBC, invasive breast cancer; COPD, chronic obstructive pulmonary disease